Showing results (151-160 of 4,156) with videos related to

Sort By:
Pageof 416
Journal of Clinical Orthopaedics and Trauma|August 12, 2022
Comparison of Exeter stem offset size for total hip arthroplasty between males and females: A retrospective series of 780 hipsGeorge Jm Hourston, Jaison Patel, Stephen M McDonnell
Cells|March 4, 2020
Cross-Presenting XCR1+ Dendritic Cells as Targets for Cancer ImmunotherapyKatherine M Audsley, Alison M McDonnell, Jason Waithman
Emergency Medicine Journal : EMJ|August 22, 2006
Alcohol levels in the emergency department: a worrying trendP Allely, W Graham, M McDonnell, et al.
Journal of Cellular Physiology|August 1, 1977
The activity of the pneumococcal autolytic system and the fate of the bacterium during ingestion by rabbit polymorphonuclear leukocytesA Tomasz, S Beckerdite, M McDonnell, et al.
Clinical Endocrinology|March 19, 2003
A 3-year prospective study to assess uterine growth in girls with Turner's syndrome by pelvic ultrasoundCiara M McDonnell, Lee Coleman, Margaret R Zacharin
Head & Neck|October 10, 1997
Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancerP Lavertu, D J Adelstein, J P Saxton, et al.
Cancer Investigation|January 1, 1997
Concurrent chemoradiotherapy for salvage in relapsed squamous cell head and neck cancerE H Tan, D J Adelstein, J P Saxton, et al.
American Journal of Clinical Oncology|October 1, 1994
Continuous course radiation therapy and concurrent combination chemotherapy for squamous cell head and neck cancerD J Adelstein, J P Saxton, M A Van Kirk, et al.
Archives of Otolaryngology--Head & Neck Surgery|February 26, 1999
Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer: an 8-year single-institution experienceP Lavertu, D J Adelstein, J P Saxton, et al.
Archives of Otolaryngology--Head & Neck Surgery|April 29, 1998
Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancerP Lavertu, J P Bonafede, D J Adelstein, et al.
Pageof 416